kund
11 minutes ago
JPM PR says upcoming presentation of topline long-term data from the Phase IIb/III ATTENTION-AD Open-Label-Extension (OLE) trial at the J.P. Morgan 2025 Healthcare Conference, taking place January 13–16, 2025, in San Francisco, CA. It will just be TLD (which is already leaked) and not detailed data.